Detection of MAGE-1 Tumor Antigen in Brain Tumor

Kurume Medical Journal

Volumn 44, Issue 1, 1997, Pages 43-51

  Kuramoto, Terukazu ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Brain tumor; Glioma; MAGE 1 protein; Specific immunotherapy; Tumor antigen

Indexed keywords

MAGEA1 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR PROTEIN;

ARTICLE; BRAIN TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GLIOMA; HUMAN; IMMUNOLOGY;

ANTIGENS, NEOPLASM; BRAIN NEOPLASMS; GLIOMA; HUMANS; NEOPLASM PROTEINS;

EID: 0030634151     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.44.43     Document Type: Article

References (14)

1. Chen Y-T, Stockert E, Chen Y, Garin-Chesa P, Rettig WJ et al. Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies, Proc Natl Acad Sci USA 1994; 91:1004-1008.
2. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora JP et al. Structure, chromosomal localization, and expression of 12 genes of the MAGE family. Immunogenetics 1994; 40:360-369.
3. Gaugler B, Van den Eynde B, Van der Bruggen P, Romero P, Gaforio JJ et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 1994; 179:921-930.
4. Kleihues P, Burger PC, and Scheithauer BW. Histologic Typing of Tumours of the Central Nervous System. In: WHO International Classification of Tumours, 2nd ed, Springer-Verlag, Berlin, Heidelberg, New York, 1993.
5. Rimoldi D, Romero P, and Carrel S. The human melanoma antigen encoding gene, MAGE-1, is expressed by other tumor cells of neuroectodermal origin such as glioblastomas and neuroblastomas. Int J Cancer 1993; 54:527-528.
6. Schultz-Thater E, Juretic A, Dellabona P, Luscher U, Siegrist W et al. MAGE-1 gene product is a cytoplasmic protein. Int J Cancer 1995; 59:435-439.
7. Shichijo S, Hayashi A, Takamori S, Tsunosue R, Hoshino T et al. Detection of MAGE-4 protein on lung cancers. Int J Cancer 1995a; 64:158-165.
8. Shichijo S, Tsunosue R, Kubo K, Kuramoto T, Tanaka Y et al. Establish of an enzyme-linked immunosorbent assay (ELISA) for measuring cellular MAGE-4 protein on human cancers. J Immunol Meth 1995b; 186:137-149.
9. Shichijo S, Tsunosue R, Imai Y, Masuoka K, Natori H et al. Preferential expression of MAGE gene family on human lymphocytic leukemias. Cancer Immunol Immunother 1995c; 41:95-103.
10. Takahashi K, Shichijo S, Noguchi M, Hirohata M, and Itho K. Identification of MAGE-1 and -4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 1995; 55:3478-3482.
11. Traversari C, van der Bruggen P, Luescher IF, Lurquin C, Chomez P et al. A nonapeptide encorded by human gene MAGE-1 is recognised on HLA-A1 by cytolytic T lymphcytes directed against tumor antigen MZ2-E. J Exp Med 1992; 176:1453-1457.
12. Van der Bruggen P, Szikora J-P, Boel P, Wildmann C, Somville M et al. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLACw*1601*. Eur J Immunol 1994; 24:2134-2140.
13. Van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991; 254:1643-1647.
14. Yamada A, Kataoka A, Shichijo S, Kamura T, Imai Y et al. Expression of MAGE-1, MAGE-2, MAGE-3/-6 and MAGE-4a/-4b genes in ovarian tumors. Int J Cancer 1995; 64:388-393.